SMS Pharmaceuticals Ltd

NSE: SMSPHARMA · BSE: 532815 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹469.55
Market cap: ₹4,163 Cr
Revenue (annual): ₹886.9 Cr
Net profit (annual): ₹102.0 Cr
P/E (TTM): 40.6×Sector 47.4×
Promoter holding: 68.07%+0.00% QoQ
FII holding: 0.65%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

1 Aug 2026 17:04 IST BSE

SMS Pharmaceuticals Results Update

SMS Pharmaceuticals reported Q1FY27 revenue of ₹207 crore, up 6% YoY. The board also approved a ₹50 crore loan infusion into its subsidiary, SMS Peptides.

Value: ₹50.00 Cr

Read the filing ↗

23 May 2026 17:46 IST NSE

Results Update

SMS Pharmaceuticals Results Update

SMS Pharmaceuticals reported FY26 revenue of ₹886.87 Crore, a 13% YoY increase. Net profit surged 47% to ₹101.98 Crore, driven by backward integration and mix.

Value: ₹886.9 Cr

Read the filing ↗